Insights into gastrointestinal microbiota-generated ginsenoside metabolites and their bioactivities

References

• Akao T, Kida H, Kanaoka M, Hattori M, Kobashi K. 1998. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J Pharm Pharmacol. 50(10):1155–1160.
   PubMed Web of Science ®Google Scholar
• An J, Ha EM. 2016. Combination therapy of lactobacillus plantarum supernatant and 5-fluouracil increases chemosensitivity in colorectal cancer cells. J Microbiol Biotechnol. 26(8):1490–1503.
   PubMed Web of Science ®Google Scholar
• Bae EA, Choo MK, Park EK, Park SY, Shin HY, Kim DH. 2002a. Metabolism of ginsenoside R(c) by human intestinal bacteria and its related antiallergic activity. Biol Pharm Bull. 25(6):743–747.
   PubMed Web of Science ®Google Scholar
• Bae EA, Han MJ, Choo MK, Park SY, Kim DH. 2002b. Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities. Biol Pharm Bull. 25(1):58–63.
   PubMed Web of Science ®Google Scholar
• Bae EA, Park SY, Kim DH. 2000. Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biol Pharm Bull. 23(12):1481–1485.
   PubMed Web of Science ®Google Scholar
• Bae EA, Shin JE, Kim DH. 2005. Metabolism of ginsenoside Re by human intestinal microflora and its estrogenic effect. Biol Pharm Bull. 28(10):1903–1908.
   PubMed Web of Science ®Google Scholar
• Ben-Eltriki M, Deb S, Adomat H, Tomlinson Guns ES. 2016. Calcitriol and 20(S)-protopanaxadiol synergistically inhibit growth and induce apoptosis in human prostate cancer cells. J Steroid Biochem Mol Biol. 158:207–219.
   PubMed Web of Science ®Google Scholar
• Cao B, Qi Y, Yang Y, Liu X, Xu D, Guo W, Zhan Y, Xiong Z, Zhang A, Wang AR, et al. 2014. 20(S)-protopanaxadiol inhibition of progression and growth of castration-resistant prostate cancer. PLoS One. 9(11):e111201.
   PubMed Web of Science ®Google Scholar
• Chae S, Kang KA, Chang WY, Kim MJ, Lee SJ, Lee YS, Kim HS, Kim DH, Hyun JW. 2009. Effect of compound K, a metabolite of ginseng saponin, combined with gamma-ray radiation in human lung cancer cells in vitro and in vivo. J Agric Food Chem. 57(13):5777–5782.
   PubMed Web of Science ®Google Scholar
• Chen L, Meng Y, Sun Q, Zhang Z, Guo X, Sheng X, Tai G, Cheng H, Zhou Y. 2016. Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation. Cell Death Dis. 7(8):e2334–e2334.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhou L, Huang J, Wang Y, Yang G, Tan Z, Wang Y, Zhou G, Liao J, Ouyang D. 2017. Single- and multiple-dose trials to determine the pharmacokinetics, safety, tolerability, and sex effect of oral ginsenoside compound K in healthy Chinese volunteers. Front Pharmacol. 8:965
   PubMed Web of Science ®Google Scholar
• Chen W, Chu S, Li H, Qiu Y. 2018. MicroRNA-146a-5p enhances ginsenoside Rh2-induced anti-proliferation and the apoptosis of the human liver cancer cell line HepG2. Oncol Lett. 16(4):5367–5374.
   PubMed Web of Science ®Google Scholar
• Chen W, Qiu Y. 2015. Ginsenoside Rh2 targets EGFR by up-regulation of miR-491 to enhance anti-tumor activity in hepatitis B virus-related hepatocellular carcinoma. Cell Biochem Biophys. 72(2):325–331.
   PubMed Web of Science ®Google Scholar
• Chen Y, Xu Y, Zhu Y, Li X. 2013. Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cells. Cancer Cell Int. 13(1):24.
   PubMed Web of Science ®Google Scholar
• Chen Z, Wei X, Shen L, Zhu H, Zheng X. 2019. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma. Cancer Sci. 110(1):389–400.
   PubMed Web of Science ®Google Scholar
• Cheng KW, Tseng CH, Yang CN, Tzeng CC, Cheng TC, Leu YL, Chuang YC, Wang JY, Lu YC, Chen YL, et al. 2017. Specific inhibition of bacterial beta-glucuronidase by pyrazolo[4,3-c]quinoline derivatives via a pH-dependent manner to suppress chemotherapy-induced intestinal toxicity. J Med Chem. 60(22):9222–9238.
   PubMed Web of Science ®Google Scholar
• Cheng LQ, Na JR, Bang MH, Kim MK, Yang DC. 2008. Conversion of major ginsenoside Rb1 to 20(S)-ginsenoside Rg3 by microbacterium sp. GS514. Phytochemistry. 69(1):218–224.
   PubMed Web of Science ®Google Scholar
• Cho SH, Chung KS, Choi JH, Kim DH, Lee KT. 2009. Compound K, a metabolite of ginseng saponin, induces apoptosis via caspase-8-dependent pathway in HL-60 human leukemia cells. BMC Cancer. 9:449
   PubMed Web of Science ®Google Scholar
• Choi HH, Jong HS, Park JH, Choi S, Lee JW, Kim TY, Otsuki T, Namba M, Bang YJ. 2003. A novel ginseng saponin metabolite induces apoptosis and down-regulates fibroblast growth factor receptor 3 in myeloma cells. Int J Oncol. 23(4):1087–1093.
   PubMed Web of Science ®Google Scholar
• Cuong TT, Yang CS, Yuk JM, Lee HM, Ko SR, Cho BG, Jo EK. 2009. Glucocorticoid receptor agonist compound K regulates Dectin-1-dependent inflammatory signaling through inhibition of reactive oxygen species. Life Sci. 85(17–18):625–633.
   PubMed Web of Science ®Google Scholar
• Dang H, Chen Y, Liu X, Wang Q, Wang L, Jia W, Wang Y. 2009. Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression. Prog Neuropsychopharmacol Biol Psychiatry. 33(8):1417–1424.
   PubMed Web of Science ®Google Scholar
• Duan Y, Nicholson RA. 2008. 20(S)-protopanaxadiol and the ginsenoside Rh2 inhibit Na + channel-activated depolarization and Na + channel-dependent amino acid neurotransmitter release in synaptic fractions isolated from mammalian brain. Comp Biochem Physiol C Toxicol Pharmacol. 147(3):351–356.
   PubMed Web of Science ®Google Scholar
• Fu Y. 2019. Biotransformation of ginsenoside Rb1 to Gyp-XVII and minor ginsenoside Rg3 by endophytic bacterium Flavobacterium sp. GE 32 isolated from Panax ginseng. Lett Appl Microbiol. 68(2):134–141.
   PubMed Web of Science ®Google Scholar
• Gao JL, Lv GY, He BC, Zhang BQ, Zhang H, Wang N, Wang CZ, Du W, Yuan CS, He TC. 2013. Ginseng saponin metabolite 20(S)-protopanaxadiol inhibits tumor growth by targeting multiple cancer signaling pathways. Oncol Rep. 30(1):292–298.
   PubMed Web of Science ®Google Scholar
• Gao Q, Zheng J. 2018. Ginsenoside Rh2 inhibits prostate cancer cell growth through suppression of microRNA-4295 that activates CDKN1A. Cell Prolif. 51(3):e12438.
   PubMed Web of Science ®Google Scholar
• Gao X, Lampraki EM, Al-Khalidi S, Qureshi MA, Desai R, Wilson JB. 2017. N-acetylcysteine (NAC) ameliorates Epstein-Barr virus latent membrane protein 1 induced chronic inflammation. PLoS One. 12(12):e0189167.
   PubMed Web of Science ®Google Scholar
• Ge G, Yan Y, Cai H. 2017. Ginsenoside Rh2 inhibited proliferation by inducing ROS mediated ER stress dependent apoptosis in lung cancer cells. Biol Pharm Bull. 40(12):2117–2124.
   PubMed Web of Science ®Google Scholar
• Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE. 2006. Metagenomic analysis of the human distal gut microbiome. Science. 312(5778):1355–1359.
   PubMed Web of Science ®Google Scholar
• Guan N, Huo X, Zhang Z, Zhang S, Luo J, Guo W. 2015. Ginsenoside Rh2 inhibits metastasis of glioblastoma multiforme through Akt-regulated MMP13. Tumor Biol. 36(9):6789–6795.
   PubMedGoogle Scholar
• Guarner F. 2006. Enteric flora in health and disease. Digestion. 73(1):5–12.
   PubMed Web of Science ®Google Scholar
• Guo XW, Hu ND, Sun GZ, Li M, Zhang PT. 2018. Shenyi capsule () plus chemotherapy versus chemotherapy for non-small cell lung cancer: a systematic review of overlapping meta-analyses. Chin J Integr Med. 24(3):227–231.
   PubMed Web of Science ®Google Scholar
• Guo XX, Li Y, Sun C, Jiang D, Lin YJ, Jin FX, Lee SK, Jin YH. 2014. p53-dependent Fas expression is critical for Ginsenoside Rh2 triggered caspase-8 activation in HeLa cells. Protein Cell. 5(3):224–234.
   PubMed Web of Science ®Google Scholar
• Hu C, Song G, Zhang B, Liu Z, Chen R, Zhang H, Hu T. 2012. Intestinal metabolite compound K of panaxoside inhibits the growth of gastric carcinoma by augmenting apoptosis via Bid-mediated mitochondrial pathway. J Cell Mol Med. 16(1):96–106.
   PubMed Web of Science ®Google Scholar
• Huang J, Peng K, Wang L, Wen B, Zhou L, Luo T, Su M, Li J, Luo Z. 2016. Ginsenoside Rh2 inhibits proliferation and induces apoptosis in human leukemia cells via TNF-alpha signaling pathway. Acta Biochim Biophys Sin (Sin.). 48(8):750–755.
   PubMed Web of Science ®Google Scholar
• Human Microbiome Project C. 2012. Structure, function and diversity of the healthy human microbiome. Nature. 486(7402):207–214.
   PubMed Web of Science ®Google Scholar
• Integrative H. 2019. The Integrative Human Microbiome Project. Nature. 569(7758):641–648.
   PubMed Web of Science ®Google Scholar
• Jeong D, Irfan M, Kim SD, Kim S, Oh JH, Park CK, Kim HK, Rhee MH. 2017. Ginsenoside Rg3-enriched red ginseng extract inhibits platelet activation and in vivo thrombus formation. J Ginseng Res. 41(4):548–555.
   PubMed Web of Science ®Google Scholar
• Jia W, Li H, Zhao L, Nicholson JK. 2008. Gut microbiota: a potential new territory for drug targeting. Nat Rev Drug Discov. 7(2):123–129.
   PubMed Web of Science ®Google Scholar
• Jiang J, Yuan Z, Sun Y, Bu Y, Li W, Fei Z. 2017. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway. Biomed Pharmacother. 96:619–625.
   PubMed Web of Science ®Google Scholar
• Jiang N, Lv JW, Wang HX, Wang Q, Lu C, Yang YJ, Huang H, Xia TJ, Lv GH, Liu XM. 2019. Antidepressant-like effects of 20(S)-protopanaxadiol in a mouse model of chronic social defeat stress and the related mechanisms. Phytother Res. 33(10):2726–2736.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Yang Y, Yang Y, Zhang Y, Yue Z, Pan Z, Ren X. 2017. Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune. Biomed Pharmacother. 96:378–383.
   PubMed Web of Science ®Google Scholar
• Jin ZH, Qiu W, Liu H, Jiang XH, Wang L. 2018. Enhancement of oral bioavailability and immune response of Ginsenoside Rh2 by co-administration with piperine. Chin J Nat Med. 16(2):143–149.
   PubMed Web of Science ®Google Scholar
• Joh EH, Lee IA, Jung IH, Kim DH. 2011. Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation – the key step of inflammation. Biochem Pharmacol. 82(3):278–286.
   PubMed Web of Science ®Google Scholar
• Jovanovski E, Bateman EA, Bhardwaj J, Fairgrieve C, Mucalo I, Jenkins AL, Vuksan V. 2014. Effect of Rg3-enriched Korean red ginseng (Panax ginseng) on arterial stiffness and blood pressure in healthy individuals: a randomized controlled trial. J Am Soc Hypertens. 8(8):537–541.
   PubMed Web of Science ®Google Scholar
• Kang A, Xie T, Zhu D, Shan J, Di L, Zheng X. 2017. Suppressive effect of Ginsenoside Rg3 against lipopolysaccharide-induced depression-like behavior and neuroinflammation in mice. J Agric Food Chem. 65(32):6861–6869.
   PubMed Web of Science ®Google Scholar
• Kang KA, Piao MJ, Kim KC, Zheng J, Yao CW, Cha JW, Kim HS, Kim DH, Bae SC, Hyun JW. 2013. Compound K, a metabolite of ginseng saponin, inhibits colorectal cancer cell growth and induces apoptosis through inhibition of histone deacetylase activity. Int J Oncol. 43(6):1907–1914.
   PubMed Web of Science ®Google Scholar
• Kang S, Kim JE, Song NR, Jung SK, Lee MH, Park JS, Yeom MH, Bode AM, Dong Z, Lee KW. 2014. The ginsenoside 20-O-beta-d-glucopyranosyl-20(S)-protopanaxadiol induces autophagy and apoptosis in human melanoma via AMPK/JNK phosphorylation. PLoS One. 9(8):e104305.
   PubMed Web of Science ®Google Scholar
• Kang S, Park SJ, Lee AY, Huang J, Chung HY, Im DS. 2018. Ginsenoside Rg3 promotes inflammation resolution through M2 macrophage polarization. J Ginseng Res. 42(1):68–74.
   PubMed Web of Science ®Google Scholar
• Kim AD, Kang KA, Kim HS, Kim DH, Choi YH, Lee SJ, Kim HS, Hyun JW. 2013. A ginseng metabolite, compound K, induces autophagy and apoptosis via generation of reactive oxygen species and activation of JNK in human colon cancer cells. Cell Death Dis. 4:e750.
   PubMed Web of Science ®Google Scholar
• Kim DY, Park MW, Yuan HD, Lee HJ, Kim SH, Chung SH. 2009. Compound K induces apoptosis via CAMK-IV/AMPK pathways in HT-29 colon cancer cells. J Agric Food Chem. 57(22):10573–10578.
   PubMed Web of Science ®Google Scholar
• Kim DY, Ro JY, Lee CH. 2015. 20(S)-Protopanaxatriol inhibits release of inflammatory mediators in immunoglobulin E-mediated mast cell activation. J Ginseng Res. 39(3):189–198.
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim M, Yun SM, Lee S, No JH, Suh DH, Kim K, Kim YB. 2017. Ginsenoside Rh2 induces apoptosis and inhibits epithelial–mesenchymal transition in HEC1A and Ishikawa endometrial cancer cells. Biomed Pharmacother. 96:871–876.
   PubMed Web of Science ®Google Scholar
• Kim SW, Kwon HY, Chi DW, Shim JH, Park JD, Lee YH, Pyo S, Rhee DK. 2003. Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg(3). Biochem Pharmacol. 65(1):75–82.
   PubMed Web of Science ®Google Scholar
• Kim TW, Choi HJ, Kim NJ, Kim DH. 2009. Anxiolytic-like effects of ginsenosides Rg3 and Rh2 from red ginseng in the elevated plus-maze model. Planta Med. 75(08):836–839.
   PubMed Web of Science ®Google Scholar
• Law CK, Kwok HH, Poon PY, Lau CC, Jiang ZH, Tai WC, Hsiao WW, Mak NK, Yue PY, Wong RN. 2014. Ginsenoside compound K induces apoptosis in nasopharyngeal carcinoma cells via activation of apoptosis-inducing factor. Chin Med. 9(1):11.
   PubMed Web of Science ®Google Scholar
• Lee IK, Kang KA, Lim CM, Kim KC, Kim HS, Kim DH, Kim BJ, Chang WY, Choi JH, Hyun JW. 2010. Compound K, a metabolite of ginseng saponin, induces mitochondria-dependent and caspase-dependent apoptosis via the generation of reactive oxygen species in human colon cancer cells. IJMS. 11(12):4916–4931.
   Web of Science ®Google Scholar
• Lee IS, Uh I, Kim KS, Kim KH, Park J, Kim Y, Jung JH, Jung HJ, Jang HJ. 2016. Anti-inflammatory effects of ginsenoside Rg3 via NF-kappaB pathway in A549 cells and human asthmatic lung tissue. J Immunol Res. 2016:1–11.
   Web of Science ®Google Scholar
• Lee JY, Jung KH, Morgan MJ, Kang YR, Lee HS, Koo GB, Hong SS, Kwon SW, Kim YS. 2013. Sensitization of TRAIL-induced cell death by 20(S)-ginsenoside Rg3 via CHOP-mediated DR5 upregulation in human hepatocellular carcinoma cells. Mol Cancer Ther. 12(3):274–285.
   PubMed Web of Science ®Google Scholar
• Lee JY, Shin JW, Chun KS, Park KK, Chung WY, Bang YJ, Sung JH, Surh YJ. 2004. Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin. Carcinogenesis. 26(2):359–367.
   PubMed Web of Science ®Google Scholar
• Lee S, Kwon MC, Jang JP, Sohng JK, Jung HJ. 2017. The ginsenoside metabolite compound K inhibits growth, migration and stemness of glioblastoma cells. Int J Oncol. 51(2):414–424.
   PubMed Web of Science ®Google Scholar
• Lee SY, Jeong JJ, Eun SH, Kim DH. 2015. Anti-inflammatory effects of ginsenoside Rg1 and its metabolites ginsenoside Rh1 and 20(S)-protopanaxatriol in mice with TNBS-induced colitis. Eur J Pharmacol. 762:333–343.
   PubMed Web of Science ®Google Scholar
• Li C, Dong Y, Wang L, Xu G, Yang Q, Tang X, Qiao Y, Cong Z. 2019. Ginsenoside metabolite compound K induces apoptosis and autophagy in non-small cell lung cancer cells via AMPK-mTOR and JNK pathways. Biochem Cell Biol. 97(4):406–414.
   PubMed Web of Science ®Google Scholar
• Li Q, Li B, Dong C, Wang Y, Li Q. 2017. 20(S)-Ginsenoside Rh2 suppresses proliferation and migration of hepatocellular carcinoma cells by targeting EZH2 to regulate CDKN2A-2B gene cluster transcription. Eur J Pharmacol. 815:173–180.
   PubMed Web of Science ®Google Scholar
• Li S, Gao Y, Ma W, Guo W, Zhou G, Cheng T, Liu Y. 2014. EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2. Tumor Biol. 35(6):5593–5598.
   PubMedGoogle Scholar
• Li W, Zhang M, Gu J, Meng ZJ, Zhao LC, Zheng YN, Chen L, Yang GL. 2012. Hypoglycemic effect of protopanaxadiol-type ginsenosides and compound K on Type 2 diabetes mice induced by high-fat diet combining with streptozotocin via suppression of hepatic gluconeogenesis. Fitoterapia. 83(1):192–198.
   PubMed Web of Science ®Google Scholar
• Li X, Tsauo J, Geng C, Zhao H, Lei X, Li X. 2018. Ginsenoside Rg3 decreases NHE1 expression via inhibiting EGF-EGFR-ERK1/2-HIF-1 alpha pathway in hepatocellular carcinoma: a novel antitumor mechanism. Am J Chin Med. 46(08):1915–1931.
   PubMed Web of Science ®Google Scholar
• Liu GW, Liu YH, Jiang GS, Ren WD. 2018. The reversal effect of Ginsenoside Rh2 on drug resistance in human colorectal carcinoma cells and its mechanism. Hum Cell. 31(3):189–198.
   PubMed Web of Science ®Google Scholar
• Liu J, Wang X, Liu P, Deng R, Lei M, Chen W, Hu L. 2013. 20(S)-Protopanaxadiol (PPD) analogues chemosensitize multidrug-resistant cancer cells to clinical anticancer drugs. Bioorg Med Chem. 21(14):4279–4287.
   PubMed Web of Science ®Google Scholar
• Liu S, Chen M, Li P, Wu Y, Chang C, Qiu Y, Cao L, Liu Z, Jia C. 2015. Ginsenoside rh2 inhibits cancer stem-like cells in skin squamous cell carcinoma. Cell Physiol Biochem. 36(2):499–508.
   PubMedGoogle Scholar
• Liu X, Sun Y, Yue L, Li S, Qi X, Zhao H, Yang Y, Zhang C, Yu H. 2016. JNK pathway and relative transcriptional factor were involved in ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells. Genet Mol Res. 15(3).
   Web of Science ®Google Scholar
• Lo SH, Hsu CT, Niu HS, Niu CS, Cheng JT, Chen ZC. 2017. Ginsenoside Rh2 improves cardiac fibrosis via PPARdelta-STAT3 signaling in type 1-like diabetic rats. Int J Mol Sci. 18(7):1384.
   PubMed Web of Science ®Google Scholar
• Lu C, Lv J, Dong L, Jiang N, Wang Y, Wang Q, Li Y, Chen S, Fan B, Wang F, et al. 2018. Neuroprotective effects of 20(S)-protopanaxatriol (PPT) on scopolamine-induced cognitive deficits in mice. Phytother Res. 32(6):1056–1063.
   PubMed Web of Science ®Google Scholar
• McConnell EL, Fadda HM, Basit AW. 2008. Gut instincts: explorations in intestinal physiology and drug delivery. Int J Pharm. 364(2):213–226.
   PubMed Web of Science ®Google Scholar
• Oh GS, Pae HO, Choi BM, Seo EA, Kim DH, Shin MK, Kim JD, Kim JB, Chung HT. 2004. 20(S)-Protopanaxatriol, one of ginsenoside metabolites, inhibits inducible nitric oxide synthase and cyclooxygenase-2 expressions through inactivation of nuclear factor-kappaB in RAW 264.7 macrophages stimulated with lipopolysaccharide. Cancer Lett. 205(1):23–29.
   PubMed Web of Science ®Google Scholar
• Oh HA, Kim DE, Choi HJ, Kim NJ, Kim DH. 2015. Anti-fatigue effects of 20(S)-protopanaxadiol and 20(S)-protopanaxatriol in mice. Biol Pharm Bull. 38(9):1415–1419.
   PubMed Web of Science ®Google Scholar
• Oh J, Kim JS. 2016. Compound K derived from ginseng: neuroprotection and cognitive improvement. Food Funct. 7(11):4506–4515.
   PubMed Web of Science ®Google Scholar
• Oh SH, Lee BH. 2004. A ginseng saponin metabolite-induced apoptosis in HepG2 cells involves a mitochondria-mediated pathway and its downstream caspase-8 activation and Bid cleavage. Toxicol Appl Pharmacol. 194(3):221–229.
   PubMed Web of Science ®Google Scholar
• Park EK, Shin YW, Lee HU, Kim SS, Lee YC, Lee BY, Kim DH. 2005. Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide. Biol Pharm Bull. 28(4):652–656.
   PubMed Web of Science ®Google Scholar
• Park JB, Kwon SK, Nagar H, Jung SB, Jeon BH, Kim CS, Oh JH, Song HJ, Kim CS. 2014. Rg3-enriched Korean Red Ginseng improves vascular function in spontaneously hypertensive rats. J Ginseng Res. 38(4):244–250.
   PubMed Web of Science ®Google Scholar
• Park JS, Shin JA, Jung JS, Hyun JW, Van Le TK, Kim DH, Park EM, Kim HS. 2012. Anti-inflammatory mechanism of compound K in activated microglia and its neuroprotective effect on experimental stroke in mice. J Pharmacol Exp Ther. 341(1):59–67.
   PubMed Web of Science ®Google Scholar
• Park S, Lee HJ, Jeong SJ, Song HS, Kim M, Lee HJ, Lee EO, Kim DH, Ahn KS, Kim SH. 2011. Inhibition of JAK1/STAT3 signaling mediates compound K-induced apoptosis in human multiple myeloma U266 cells. Food Chem Toxicol. 49(6):1367–1372.
   PubMed Web of Science ®Google Scholar
• Park SY, Bae EA, Sung JH, Lee SK, Kim DH. 2001. Purification and characterization of ginsenoside Rb1-metabolizing beta-glucosidase from Fusobacterium K-60, a human intestinal anaerobic bacterium. Biosci Biotechnol Biochem. 65(5):1163–1169.
   PubMed Web of Science ®Google Scholar
• Peng B, He R, Xu Q, Yang Y, Hu Q, Hou H, Liu X, Li J. 2019. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway. Pharmacol Res. 142:1–13.
   PubMed Web of Science ®Google Scholar
• Qian J, Li J, Jia JG, Jin X, Yu DJ, Guo CX, Xie B, Qian LY. 2016. Ginsenoside-Rh2 inhibits proliferation and induces apoptosis of human gastric cancer SGC-7901 side population cells. Asian Pac J Cancer Prev. 17(4):1817–1821.
   PubMedGoogle Scholar
• Ramon S, Dalli J, Sanger JM, Winkler JW, Aursnes M, Tungen JE, Hansen TV, Serhan CN. 2016. The protectin PCTR1 is produced by human M2 macrophages and enhances resolution of infectious inflammation. Am J Pathol. 186(4):962–973.
   PubMed Web of Science ®Google Scholar
• Saba E, Irfan M, Jeong D, Ameer K, Lee YY, Park CK, Hong SB, Rhee MH. 2019. Mediation of antiinflammatory effects of Rg3-enriched red ginseng extract from Korean Red Ginseng via retinoid X receptor alpha-peroxisome-proliferating receptor gamma nuclear receptors. J Ginseng Res. 43(3):442–451.
   PubMed Web of Science ®Google Scholar
• Salsberry PJ, Smith MC, Boyd CO. 1989. Phenomenological research in nursing: commentary and responses. Nurs Sci Q. 2(1):9–19.
   PubMedGoogle Scholar
• Schwartz TL, Azhar N, Cole K, Hopkins G, Nihalani N, Simionescu M, Husain J, Jones N. 2004. An open-label study of adjunctive modafinil in patients with sedation related to serotonergic antidepressant therapy. J Clin Psychiatry. 65(9):1223–1227.
   PubMed Web of Science ®Google Scholar
• Shi Q, Li J, Feng Z, Zhao L, Luo L, You Z, Li D, Xia J, Zuo G, Chen D. 2014. Effect of ginsenoside Rh2 on the migratory ability of HepG2 liver carcinoma cells: recruiting histone deacetylase and inhibiting activator protein 1 transcription factors. Mol Med Rep. 10(4):1779–1785.
   PubMed Web of Science ®Google Scholar
• Sousa T, Paterson R, Moore V, Carlsson A, Abrahamsson B, Basit AW. 2008. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm. 363(1-2):1–25.
   PubMed Web of Science ®Google Scholar
• Spanogiannopoulos P, Bess EN, Carmody RN, Turnbaugh PJ. 2016. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat Rev Microbiol. 14(5):273–287.
   PubMed Web of Science ®Google Scholar
• Stringer AM, Gibson RJ, Logan RM, Bowen JM, Yeoh AS, Keefe DM. 2008. Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats. Cancer Biol Ther. 7(12):1919–1925.
   PubMed Web of Science ®Google Scholar
• Sun J, Hu S, Song X. 2007. Adjuvant effects of protopanaxadiol and protopanaxatriol saponins from ginseng roots on the immune responses to ovalbumin in mice. Vaccine. 25(6):1114–1120.
   PubMed Web of Science ®Google Scholar
• Sun L, Wang Q, Liu X, Brons NH, Wang N, Steinmetz A, Lv Y, Liao Y, Zheng H. 2011. Anti-cancer effects of 20(S)-protopanoxadiol on human acute lymphoblastic leukemia cell lines Reh and RS4;11. Med Oncol. 28(3):813–821.
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu Y, Chen K. 2016. Roles and mechanisms of ginsenoside in cardiovascular diseases: progress and perspectives. Sci China Life Sci. 59(3):292–298.
   PubMed Web of Science ®Google Scholar
• Tang XP, Tang GD, Fang CY, Liang ZH, Zhang LY. 2013. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells. WJG. 19(10):1582–1592.
   PubMed Web of Science ®Google Scholar
• Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. 2003. Degradation of ginsenosides in humans after oral administration. Drug Metab Dispos. 31(8):1065–1071.
   PubMed Web of Science ®Google Scholar
• Tong-Lin Wu T, Tong YC, Chen IH, Niu HS, Li Y, Cheng JT. 2018. Induction of apoptosis in prostate cancer by ginsenoside Rh2. Oncotarget. 9(13):11109–11118.
   PubMedGoogle Scholar
• Uguz F, Sahingoz M, Gungor B, Aksoy F, Askin R. 2015. Weight gain and associated factors in patients using newer antidepressant drugs. Gen Hosp Psychiatry. 37(1):46–48.
   PubMed Web of Science ®Google Scholar
• Wallace BD, Wang H, Lane KT, Scott JE, Orans J, Koo JS, Venkatesh M, Jobin C, Yeh L-A, Mani S, et al. 2010. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science. 330(6005):831–835.
   PubMed Web of Science ®Google Scholar
• Wang CZ, Du GJ, Zhang Z, Wen XD, Calway T, Zhen Z, Musch MW, Bissonnette M, Chang EB, Yuan CS. 2012. Ginsenoside compound K, not Rb1, possesses potential chemopreventive activities in human colorectal cancer. Int J Oncol. 40(6):1970–1976.
   PubMed Web of Science ®Google Scholar
• Wang CZ, Zhang Z, Wan JY, Zhang CF, Anderson S, He X, Yu C, He TC, Qi LW, Yuan CS. 2015. Protopanaxadiol, an active ginseng metabolite, significantly enhances the effects of fluorouracil on colon cancer. Nutrients. 7(2):799–814.
   PubMed Web of Science ®Google Scholar
• Wang J, Tian L, Khan MN, Zhang L, Chen Q, Zhao Y, Yan Q, Fu L, Liu J. 2018. Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-kappaB mediated epithelial-mesenchymal transition and stemness. Cancer Lett. 415:73–85.
   PubMed Web of Science ®Google Scholar
• Wang JH, Nao JF, Zhang M, He P. 2014. 20(s)-ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K/Akt and XIAP pathways. Tumor Biol. 35(12):11985–11994.
   PubMedGoogle Scholar
• Wilson ID, Nicholson JK. 2017. Gut microbiome interactions with drug metabolism, efficacy, and toxicity. Transl Res. 179:204–222.
   PubMed Web of Science ®Google Scholar
• Xia T, Wang JC, Xu W, Xu LH, Lao CH, Ye QX, Fang JP. 2014. 20S-Ginsenoside Rh2 induces apoptosis in human Leukaemia Reh cells through mitochondrial signaling pathways. Biol Pharm Bull. 37(2):248–254.
   PubMed Web of Science ®Google Scholar
• Xu C, Teng J, Chen W, Ge Q, Yang Z, Yu C, Yang Z, Jia W. 2010. 20(S)-protopanaxadiol, an active ginseng metabolite, exhibits strong antidepressant-like effects in animal tests. Prog Neuropsychopharmacol Biol Psychiatry. 34(8):1402–1411.
   PubMed Web of Science ®Google Scholar
• Yan Q, Zhou XW, Zhou W, Li XW, Feng MQ, Zhou P. 2008. Purification and properties of a novel beta-glucosidase, hydrolyzing ginsenoside Rb1 to CK, from Paecilomyces Bainier. J Microbiol Biotechnol. 18(6):1081–1089.
   PubMed Web of Science ®Google Scholar
• Yang CS, Ko SR, Cho BG, Shin DM, Yuk JM, Li S, Kim JM, Evans RM, Jung JS, Song DK, et al. 2008. The ginsenoside metabolite compound K, a novel agonist of glucocorticoid receptor, induces tolerance to endotoxin-induced lethal shock. J Cell Mol Med. 12(5A):1739–1753.
   PubMed Web of Science ®Google Scholar
• Yang J, Yuan D, Xing T, Su H, Zhang S, Wen J, Bai Q, Dang D. 2016. Ginsenoside Rh2 inhibiting HCT116 colon cancer cell proliferation through blocking PDZ-binding kinase/T-LAK cell-originated protein kinase. J Ginseng Res. 40(4):400–408.
   PubMed Web of Science ®Google Scholar
• Yang QY, Lai XD, Ouyang J, Yang JD. 2018. Effects of Ginsenoside Rg3 on fatigue resistance and SIRT1 in aged rats. Toxicology. 409:144–151.
   PubMed Web of Science ®Google Scholar
• Yoon SJ, Park JY, Choi S, Lee JB, Jung H, Kim TD, Yoon SR, Choi I, Shim S, Park YJ. 2015. Ginsenoside Rg3 regulates S-nitrosylation of the NLRP3 inflammasome via suppression of iNOS. Biochem Biophys Res Commun. 463(4):1184–1189.
   PubMed Web of Science ®Google Scholar
• Yuan Z, Jiang H, Zhu X, Liu X, Li J. 2017. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-kappaB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer. Biomed Pharmacother. 89:227–232.
   PubMed Web of Science ®Google Scholar
• Zhang H, Xu HL, Fu WW, Xin Y, Li MW, Wang SJ, Yu XF, Sui DY. 2014. 20(S)-Protopanaxadiol induces human breast cancer MCF-7 apoptosis through a caspase-mediated pathway. Asian Pac J Cancer Prev. 15(18):7919–7923.
   PubMedGoogle Scholar
• Zhang H, Xu HL, Wang YC, Lu ZY, Yu XF, Sui DY. 2018. 20(S)-Protopanaxadiol-induced apoptosis in MCF-7 breast cancer cell line through the inhibition of PI3K/AKT/mTOR signaling pathway. Int J Mol Sci. 19(4):E1053.
   PubMed Web of Science ®Google Scholar
• Zhang K, Li Y. 2016. Effects of ginsenoside compound K combined with cisplatin on the proliferation, apoptosis and epithelial mesenchymal transition in MCF-7 cells of human breast cancer. Pharm Biol. 54(4):561–568.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Hong B, Wu S, Niu T. 2015a. Inhibition of prostatic cancer growth by ginsenoside Rh2. Tumor Biol. 36(4):2377–2381.
   PubMedGoogle Scholar
• Zhang R, Chung Y, Kim HS, Kim DH, Kim HS, Chang WY, Hyun JW. 2013a. 20-O-(beta-D-glucopyranosyl)-20(S)-protopanaxadiol induces apoptosis via induction of endoplasmic reticulum stress in human colon cancer cells. Oncol Rep. 29(4):1365–1370.
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhang Y, Ma X, Chen Y. 2015b. Effects of acupuncturing Pishu combined with Ginsenoside Rg3 on the immune function of rats with chronic fatigue. Int J Clin Exp Med. 8(10):19022–19029.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang S, Sun Q, Jiao W, Yan Y, Zhang X. 2018. Compound K induces endoplasmic reticulum stress and apoptosis in human liver cancer cells by regulating STAT3. Molecules. 23(6):E1482.
   Web of Science ®Google Scholar
• Zhang YL, Zhang R, Xu HL, Yu XF, Qu SC, Sui DY. 2013b. 20(S)-protopanaxadiol triggers mitochondrial-mediated apoptosis in human lung adenocarcinoma A549 cells via inhibiting the PI3K/Akt signaling pathway. Am J Chin Med. 41(05):1137–1152.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Du GJ, Wang CZ, Wen XD, Calway T, Li Z, He TC, Du W, Bissonnette M, Musch MW, et al. 2013c. Compound K, a Ginsenoside metabolite, inhibits colon cancer growth via multiple pathways including p53-p21 interactions. IJMS. 14(2):2980–2995.
   Web of Science ®Google Scholar
• Zheng M, Xin Y, Li Y, Xu F, Xi X, Guo H, Cui X, Cao H, Zhang X, Han C. 2018. Ginsenosides: a potential neuroprotective agent. Biomed Res Int. 2018:8174345.
   Web of Science ®Google Scholar
• Zheng ZZ, Ming YL, Chen LH, Zheng GH, Liu SS, Chen QX. 2014. Compound K-induced apoptosis of human hepatocellular carcinoma MHCC97-H cells in vitro. Oncol Rep. 32(1):325–331.
   PubMed Web of Science ®Google Scholar
• Zhou B, Yan Z, Liu R, Shi P, Qian S, Qu X, Zhu L, Zhang W, Wang J. 2016. Prospective study of transcatheter arterial chemoembolization (TACE) with Ginsenoside Rg3 versus TACE alone for the treatment of patients with advanced hepatocellular carcinoma. Radiology. 280(2):630–639.
   PubMed Web of Science ®Google Scholar
• Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL. 2019. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature. 570(7762):462–467.
   PubMed Web of Science ®Google Scholar